
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
Breast Cancer Update
00:00
Empowering Patients: Endocrine Resistance Insights in Breast Cancer
This chapter emphasizes the essential role of patient involvement in breast cancer treatment decisions, particularly in hormone receptor-positive cases. It explores clinical data on endocrine resistance, notably the impact of ESR1 mutations on treatment efficacy and ongoing trials in the context of novel therapies.
Play episode from 13:05
Transcript


